TITLE

Autoimmune Encephalopathy

AUTHOR(S)
Caselli, Richard J.; Drazkowski, Joseph F.; Wingerchuk, Dean M.
PUB. DATE
October 2010
SOURCE
Mayo Clinic Proceedings;Oct2010, Vol. 85 Issue 10, p878
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
An introduction to the journal is presented in which the editor discusses autoimmune dementia treated with immunotherapy, the association between Hashimoto disease of the thyroid and encephalopathy and the descriptions of paraneoplastic autoimmune encephalopathies.
ACCESSION #
54592669

 

Related Articles

  • Immuno- and genetic therapy in autoimmune diseases. Chernajovsky, Y; Dreja, H; Daly, G; Annenkov, A; Gould, D; Adams, G; Croxford, J L; Baker, D; Podhajcer, O L; Mageed, R A // Genes & Immunity;Jun2000, Vol. 1 Issue 5, p295 

    Animal models of autoimmune disease have been developed that mimic some aspects of the pathophysiology of human disease. These models have increased our understanding of possible mechanisms of pathogenesis at the molecular and cellular level and have been important in the testing, development...

  • Transient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adults. Yu, Shiguang; Ellis, Jason S.; Dunn, Robert; Kehry, Marilyn R.; Braley-Mullen, Helen // International Immunology;Apr2012, Vol. 24 Issue 4, p233 

    B-cell depletion therapy can be effective for treating B-cell lymphomas as well as many human and murine autoimmune diseases. B-cell-deficient mice are normally resistant to spontaneous autoimmune thyroiditis (SAT), but they develop SAT if regulatory T cells are transiently depleted during the...

  • Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. de Vries, L.; Bulvik, S.; Phillip, M. // Archives of Disease in Childhood;Jan2009, Vol. 94 Issue 1, p33 

    Objective: To investigate the clinical manifestations of autoimmune thyroiditis (AlT) leading to referral in children and adolescents, in addition to disease course and long- term outcome. Design: Chart review. Setting: Major tertiary hospital. Patients: 114 children/adolescents (92 female, 22...

  • Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support. Cohen, Yossi; Polliack, Aaron; Nagler, Arnon // Current Pharmaceutical Design;Jan2003, Vol. 9 Issue 3, p279 

    Immunological manipulations are the basis for modern treatments of autoimmune diseases (AID). Targeted immune suppression with lymphopenic based chemotherapy, and monoclonal anti B or T lymphocytic antibodies, are integral part of the conditioning for stem cell transplantation (SCT). Immune...

  • New Approach to Immunotherapy Against Organ-specific Autoimmune Diseases with T Cell Receptor and Chemokine Receptor DNA Vaccines. Matsumoto, Yoh // Current Drug Targets - Immune, Endocrine & Metabolic Disorders;Mar2005, Vol. 5 Issue 1, p73 

    Organ-specific autoimmune diseases are characterized by the presence of relapse and remittance of the clinical signs, and last for a long period of time in most cases without an appropriate treatment. Immunopathologically, T cells that respond to organ-specific autoantigens play an important...

  • Low Dose Allergen Immunotherapy (LDA): The Allergy Treatment of the Future -- Here Now. Shrader Jr., W. A. // Townsend Letter;Apr2012, Issue 345, p46 

    The article presents the low dose allergen immunotherapy (LDA) as a unique method of immunotherapy which appears as a long-lasting treatment option for allergy and other autoimmune illnesses. LDA involves desensitization combined with a wide variety of extremely low-dose allergens given with the...

  • Interleukin-2/tumour infiltrating lymphocytes.  // Reactions Weekly;6/13/2009, Issue 1256, p19 

    The article describes the case of a woman who developed ocular and systemic autoimmune disorders while receiving immunotherapy with interleukin-2 and tumour infiltrating lymphocytes (TIL) for recurrent metastatic melanoma. He had received high-dose interleukin-2 infusions in 2005 and was...

  • Therapeutic manipulation of immune tolerance in allergic disease. Akdis, Mübeccel; Akdis, Cezmi A.; Akdis, Mübeccel // Nature Reviews Drug Discovery;Aug2009, Vol. 8 Issue 8, p645 

    Immune tolerance - the adaptation of the immune system to external antigens or allergens - might be therapeutically manipulated to restore normal immunity in conditions such as allergy, asthma and autoimmune diseases. The field of allergen-specific immunotherapy is experiencing exciting and...

  • Immunotherapy-Based Strategies for the Treatment of Autoimmune Diabetes: Searching for the Cure. Phillips, Brett E.; Trucco, Massimo // Current Pharmaceutical Design;10/1/2011, Vol. 17 Issue 29, p3217 

    Type 1 Diabetes is an autoimmune disease most often associated with elevated and uncontrolled blood glucose levels. Therefore patient education and treatment compliance is often focused on disease maintenance through insulin treatment and blood glucose control. Unfortunately insulin therapy...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics